Gene · 6445
Papers1,688
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,688
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Defining clinical endpoints in limb girdle muscular dystrophy: a GRASP-LGMD study. | BMC Neurol | 2024 | 38491364 | PubTator, text mining | PubMed |
| Molecular Diagnosis of Limb-Girdle Muscular Dystrophy Using Next-Generation Sequencing Panels. | Mol Syndromol | 2024 | 38357257 | PubTator, text mining | PubMed |
| Alleviating CB2-Dependent ER Stress and Mitochondrial Dysfunction Improves Chronic Cerebral Hypoperfusion-Induced Cognitive Impairment. | J Neuroimmune Pharmacol | 2024 | 38214766 | PubTator, text mining | PubMed |
| Cultured Rat Hippocampal Neurons Exposed to the Mitochondrial Uncoupler Carbonyl Cyanide Chlorophenylhydrazone Undergo a Rapid, Presenilin-Dependent Change in Neuronal Properties. | Int J Mol Sci | 2024 | 38203751 | PubTator, text mining | PubMed |
| Gene therapy with bidridistrogene xeboparvovec for limb-girdle muscular dystrophy type 2E/R4: phase 1/2 trial results. | Nat Med | 2024 | 38177855 | PubTator, text mining | PubMed |
| Relevance of the endoplasmic reticulum-mitochondria axis in cancer diagnosis and therapy. | Exp Mol Med | 2024 | 38172597 | PubTator, text mining | PubMed |
| Disruption of MAM integrity in mutant FUS oligodendroglial progenitors from hiPSCs. | Acta Neuropathol | 2024 | 38170217 | PubTator, text mining | PubMed |
| MAPK1 Mediates MAM Disruption and Mitochondrial Dysfunction in Diabetic Kidney Disease via the PACS-2-Dependent Mechanism. | Int J Biol Sci | 2024 | 38169625 | PubTator, text mining | PubMed |
| Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions. | Nat Commun | 2024 | 38168093 | PubTator, text mining | PubMed |
| Serum proteomic panel validated for prediction of knee osteoarthritis progression. | Osteoarthr Cartil Open | 2024 | 38116469 | PubTator, text mining | PubMed |
| Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer. | Clin Transl Radiat Oncol | 2024 | 38111609 | PubTator, text mining | PubMed |
| Epithelial ovarian cancer survival by race and ethnicity in an equal-access healthcare population. | Br J Cancer | 2024 | 38057396 | PubTator, text mining | PubMed |
| Effectiveness of SplashGuard Caregiver prototype in reducing the risk of aerosol transmission in intensive care unit rooms of SARS-CoV-2 patients: a prospective and simulation study. | J Hosp Infect | 2024 | 38040038 | PubTator, text mining | PubMed |
| Interleukin-10 promoter polymorphisms and haplotypes in patients with Guillain-Barré syndrome. | Ann Clin Transl Neurol | 2024 | 37955408 | PubTator, text mining | PubMed |
| ARL6IP1 gene delivery reduces neuroinflammation and neurodegenerative pathology in hereditary spastic paraplegia model. | J Exp Med | 2024 | 37934410 | PubTator, text mining | PubMed |
| Biallelic SOX8 Variants Associated With Novel Syndrome With Myopathy, Skeletal Deformities, Intellectual Disability, and Ovarian Dysfunction. | Neurol Genet | 2023 | 38235364 | PubTator, text mining | PubMed |
| The Protective Role of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Protein Sigma-1 Receptor in Regulating Endothelial Inflammation and Permeability Associated with Acute Lung Injury. | Cells | 2023 | 38201208 | PubTator, text mining | PubMed |
| Hypomagnetic Conditions and Their Biological Action (Review). | Biology (Basel) | 2023 | 38132339 | PubTator, text mining | PubMed |
| The reciprocal regulation between mitochondrial-associated membranes and Notch signaling in skeletal muscle atrophy. | Elife | 2023 | 38099641 | PubTator, text mining | PubMed |
| Renoprotective effects of combination treatment with sodium-glucose cotransporter inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus according to preceding medication. | Diab Vasc Dis Res | 2023 | 38096503 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6445/papers?page=6